Neuroendocrine tumours may be broadly divided into pancreatic endocrine tumours (PETs)
and carcinoid neuroendocrine tumours (NETs). In both cases, patients may present with a …

Pancreatic neuroendocrine tumors (PNETs) are rare and represent a heterogeneous
disease. PNET can be functioning or non-functioning with different clinical presentations and …

Neuroendocrine tumours (NETs) are often thought to be rare and rather recherché cancers
which are of little concern to the general physician, surgeon or radiologist because of their …

Several diagnostic imaging techniques including computed tomography (CT), magnetic
resonance imaging (MRI), positron emission tomography (PET)/CT, singlephoton emission …

Pancreatic neuroendocrine tumors (PNETs) are very rare, accounting for 1-2% of all
pancreatic neoplasms. They are classified into functioning and non-functioning and their …

Pancreatic neuroendocrine tumors (PNETs) are relatively rare; however, the incidence has
increased over the last few decades. They are classified as functional or non-functional …

Introduction: Recently, there have been a number of advances in imaging pancreatic
neuroendocrine tumors (panNETs), as well as other neuroendocrine tumors (NETs), which …

Neuroendocrine tumours (NETs) comprise a heterogeneous group of neoplasms with very
varying clinical expression. A functioning NET, for instance in the pancreas, may be very …

Pancreatic neuroendocrine tumors (PNETs) account for only 3% of pancreatic malignancies,
but have an increasing incidence, currently 0.3 to 0.4 per 100,000. 1–3 They are notably …

Imaging of gastroenteropancreatic neuroendocrine tumors can be broadly divided into
anatomic and functional techniques. Anatomic imaging determines the local extent of the …